Brain Cortex
|
Treatment
|
Neurotransmitter (ng/g brain tissue)
|
---|
DA
|
DOPAC
|
5HT
|
5HIAA
|
Norepinephrine
|
---|
Frontal Cortex
|
Control
|
1277.7 ± 332.8b
|
741.7 ± 115.5b
|
797.3 ± 72.8a
|
863.0 ± 47.2a
|
409.1 ± 107.3c
|
|
STZ-PBS
|
238.4 ± 27.00.2b
|
175.9 ± 55.5c
|
323.3 ± 93.4c
|
99.7 ± 11.5c
|
685.6.9 ± 34.4b
|
|
STZ-Rosi
|
851.5 ± 307.3b
|
615.3 ± 54.2b
|
594.5 ± 220.3bc
|
283.7 ± 39.9b
|
939.2 ± 81.8a
|
|
STZ-OFE
|
2343.2 ± 824.4a
|
1467.4 ± 136.6a
|
931.1 ± 45.6a
|
939.5.7 ± 59.8a
|
861.33 ± 84.4a
|
Striatum
|
Control
|
986.8 ± 73.2b
|
1013.1 ± 101.6ab
|
936.7 ± 93.8a
|
863.0.0 ± 47.2b
|
916.52 ± 49.9a
|
|
STZ-PBS
|
806.1 ± 138.3 b
|
681.6 ± 61.2c
|
583.1 ± 97.4b
|
481.0 ± 33.9c
|
613.7 ± 26.2b
|
|
STZ-Rosi
|
1185.3 ± 423.9b
|
797.6 ± 103.1bc
|
613.8 ± 129.7b
|
491.7 ± 20.2c
|
731.8 ± 55.9b
|
|
STZ-OFE
|
2760.7 ± 323.0a
|
1069.9 ± 120.8a
|
693.2 ± 96.7ab
|
716.7 ± 57.1a
|
679.6 ± 65.7b
|
Hippocampus
|
Control
|
288.5 ± 72.8a
|
111.7 ± 30.5b
|
1041.9 ± 103.6b
|
1040.7 ± 71.6a
|
257.6 ± 63.9c
|
|
STZ-PBS
|
84.6 ± 5.1bc
|
129.0 ± 46.9b
|
620.2 ± 66.2c
|
219.0 ± 5.9b
|
423.5 ± 85.8bc
|
|
STZ-Rosi
|
19.9 ± 6.2c
|
49.1 ± 28.0bc
|
864.3 ± 41.0b
|
185.4 ± 63.2b
|
702.9 ± 12.1a
|
|
STZ-OFE
|
255.1 ± 56.3a
|
317.4 ± 121.3a
|
1622.7 ± 83.0a
|
280.8 ± 61.5b
|
592.2 ± 107.9ab
|
- DA: dopamine; DOPAC: 3,4-dihydroxy phenlactic acid; 5-HT: 5-hydroxytryptamine; 5-H1AA: 5-hydroxy indole acetic acid. One way ANOVA followed by Tukey’s post hoc test was performed for multiple comparisons. Means in a row with different superscripts, such as a, b, c, ab, bc, is significantly different (p <= 0.05). Values are present as mean ± SEM, n = 6 in control group and n = 8 in the ogher groups